Error loading player: No playable sources found
Unmatched Capability to Elucidate the Complex Size and Charge Variants of Protein Therapeutics using Native Mass Spectrometry with the Orbitrap Ascend Biopharma Tribrid MS | Presented by Thermo Fisher Scientific
Date
January 30, 2025
This product is not available for individual purchase, but it is available as part of the following products:
Session Speakers:
Elucidation of a Unique High Molecular Mass Species in a Bispecific Antibody Using Native Electrospray Ionization Orbitrap Mass Spectrometry
Andrew Saati, Pfizer, Inc.
Improving Proteoform Specific Microheterogeneity Assessment of Biopharmaceuticals Using an Orbitrap Ascend BioPharma Mass Spectrometer
Corentin Beaumal, National Institute for Bioprocessing Research and Training (NIBRT)
Speakers
General
Related Products
Parallel Session 6B: The Critical Need to Protect the Horseshoe Crab: Initiatives from Industry, Suppliers and Regulators to Replace the LAL Assay
The pharmaceutical industry is increasingly viewed as a key sector systemically important in reversing nature loss. One of the sector’s key dependencies is on the horseshoe crab , a species that is vital to marine ecosystems only located in a few locations globally…
Parallel Session 2A - Science vs the Fear Factor: Alternative Potency Assays for Recombinant Biologics and Vaccines
Potency analytical control strategies are critical to support biopharmaceutical drug and vaccine development throughout the product lifecycle…
Parallel Session 5A - Integrated Control Strategy for Combination Products
Drug-device combination products such as prefilled syringes, autoinjectors, etc. can play an important role to ensure patient convenience, compliance, and enhance therapeutic impact of the drug…
Turning Mandates into Momentum: How CASSS Can Help Sonia Vallabh?
As a follow-up to Tuesday's very impactful Keynote presentation, join us in-person or online as we come together as a community and brainstorm ways to further Sonia's mission to prevent prion disease…
